Gary Carter, MMRDirector of Market Research at Agilent Technologies, Inc
Gary Carter is currently Director of Marketing and Strategy for Agilent’s Nucleic Acids Solutions Division which manufactures oligonucleotide API’s for clinical and commercial use. Mr. Carter has maintained a database of all clinical trials, drug approvals, investments and deals in the therapeutic oligo space for the past 18 years. This database has been used in the creation of attrition and progression rates for clinical oligo therapeutic programs and to benchmark the oligo therapeutic space against the broader biotech drug development market. Mr. Carter has a Masters degree in market research and 25 years’ experience conducting market research and strategy development projects for a wide range of companies.